RS

Ramesh Shankarrao More

Active Director Additional Director DIN 06601971
DIN 06601971 First appointment Jun 2012 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramesh Shankarrao More

Data last updated:

Ramesh Shankarrao More is an Additional Director at Mcmurry Biopharmachem Private Limited (since 2012). The company operates in Chemicals.

DIN 06601971
Primary Designation Additional Director
Industry Chemicals
First Appointment 07 Jun 2012
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director07 Jun 20122009Active

Board colleagues of Ramesh Shankarrao More

NameDINCompanyDesignation
Mukund Mohan Desai02831408Mcmurry Biopharmachem Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Mcmurry Biopharmachem Private Limited
Premium access

Shareholding and investment profile for Ramesh Shankarrao More

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Shankarrao More

Ramesh Shankarrao More currently holds 1 directorship: Mcmurry Biopharmachem Private Limited (Additional Director, since 07 Jun 2012).

Ramesh Shankarrao More was first appointed on 07 Jun 2012 as Additional Director at Mcmurry Biopharmachem Private Limited.

The current boards of Ramesh Shankarrao More's companies include Mukund Mohan Desai (Mcmurry Biopharmachem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available